Bridging the Gap: Advancing First-Line Therapy for Patients With Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
C
Carmine Valenza
(Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MA)
N
Nancy A. Nixon
(Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada)
W
Winson Y. Cheung
(Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada)
S
Sara M. Tolaney
(Department of Medical Oncology, Dana-Farber Cancer Institute)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 17
Published
June 10, 2026
Pages
1571-1574
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (4)
C
Carmine Valenza
Breast Oncology Program, Dana-Farber Cancer Institute, Boston, MA
N
Nancy A. Nixon
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
W
Winson Y. Cheung
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
S
Sara M. Tolaney
Department of Medical Oncology, Dana-Farber Cancer Institute
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001